Merck KGaA and Eli Lilly and Company experienced stock declines on July 20, 2026, amid market sentiment shifts.

The entities involved

• Merck KGaA →

  German multinational science and technology company

  • MSD, which operates as Merck & Co. in the US and Canada, has appointed Vidhya as Associate Vice President.Mon 12:02
  • Merck KGaA filed required 13F reports with the Securities and Exchange Commission regarding institutional holdings on June 15, 2026.Mon 02:05
• Eli Lilly and Company →

  American pharmaceutical company

  • ExxonMobil, Berkshire Hathaway, and Eli Lilly are top holdings in the Avantis ETF.Mon 17:18
  • The FDA approved Olumiant for pediatric indications on September 1, 2026.Mon 05:59

Related events

• A combination drug from Merck KGaA and Inhibrx Biosciences showed a higher response rate, leading to a stock price drop reported by Reuters.Thu 20:05
• Several healthcare ETFs hold major pharmaceutical companies like Eli Lilly, J&J, and Novo Nordisk as top 3 positions, leading to competition for investor capital.Jun 19
• Financial results and stock performance comparisons among AbbVie, Johnson & Johnson, Eli Lilly, and Merck.Aug 14